Advertisement
Advertisement

PLRX

PLRX logo

Pliant Therapeutics, Inc. Common Stock

1.22
USD
Sponsored
-0.02
-1.61%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

1.25

+0.03
+2.21%

Pliant Therapeutics, Inc. Common Stock Profile

About

Pliant Therapeutics Inc. is a late-stage biopharmaceutical company which involved in the discovery and development of novel therapeutics for the treatment of fibrotic diseases. The company's lead product candidate includes bexotegrast. Pliant Therapeutics Inc., formerly known as PLANT THERAPEUT, is based in SOUTH SAN FRANCISCO, Calif.

Info & Links

CEO

Bernard Coulie

Headquarters

331 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO, CA 94080, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

http://pliantrx.com

Auditor

Deloitte & Touche LLP

Share holders

21

Employees

49

Pliant Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

77.21M

Enterprise Value

31.76M

Enterprise Value/EBITDA(ttm)

-0.21

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.46

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-68.71%

Return on Invested Capital(ttm)

-61.24%

Return on Assets(ttm)

-51.47%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-150.72M

Net Income Available to Common(ttm)

-149.34M

Diluted EPS(ttm)

-2.44

Share Statistics

Beta (5Y Monthly)

1.23

52-Week Change

-16.44%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

61.91M

Dividend Yield

0.00%

Float4

56.96M

% Held by Insiders

8.00%

% Held by Institutions

97.30%

Balance Sheet

Total Cash(mrq)

190.94M

Total Cash Per Share(mrq)

3.08

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

12.00%

Quick Ratio(mrq)

12.00%

Book Value Per Share(mrq)

2.95

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.09

Free Cash Flow(ytd)

-128.56M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement